English Українська
  • Main
  • Useful links
  • Information for Contributors
  • About
  • Editorial board

  • Article
    V. M. Zhdan, M. V. Tkachenko, E. M. Kіtura, M. Y. Babanina, O. A. Kyrian

    OSTEOARTHRITIS AND METABOLIC SYNDROME: UNITY OF PATHOGENETIC MECHANISMS


    About the author: V. M. Zhdan, M. V. Tkachenko, E. M. Kіtura, M. Y. Babanina, O. A. Kyrian
    Heading CLINICAL MEDICINE
    Type of article Scentific article
    Annotation The article presents the results of the examination of the functional state of the joints of 116 people. There was a study of lipid profile, insulin resistance, systemic inflammation activity in patients with osteoarthritis, osteoarthritis in combination with metabolic syndrome. According to the results of the study, significant changes in the above-mentioned predictors were found in patients with osteoarthritis in combination with metabolic syndrome compared to groups of healthy individuals and patients with osteoarthritis. Thus, we found a probable increase in total cholesterol by 1.3 times, triglycerides by 1.4 times, cholesterol of very-low-density lipoproteins by 1.8 times compared with the corresponding values in patients with osteoarthritis. Exceedances in TNF- and IL-1 indices were found to be 3.6 and 2.5-fold higher, respectively, in patients with osteoarthritis in combination with metabolic syndrome compared with other study groups. With the growing number of patients with osteoarthritis in combination with metabolic syndrome in Ukraine and around the world, the study of the unity of pathogenetic mechanisms and the possibility of finding new treatments is critical.
    Tags dyslipidemia, insulin resistance, atherosclerosis, cytokines, patient's quality of life
    Bibliography
    • Alekseyeva LI. Novyye predstavleniya o patogeneze osteoartrita, rol metabolicheskikh narusheniy. Ozhireniye i metabolizm. 2019;16(2):75–82. [in Russian]
    • Holovach ІYU. Metabolichnyy fenotyp osteoartrytu. Suchasni pohlyady na patohenez, mekhanizmy prohresuvannya ta pidkhody do likuvannya. Ukrayinskyy revmatolohichnyy zhurnal. 2018;71(1):3–8. [in Ukrainian]
    • Zhdan VM, Tkachenko MV. Vplyv rozuvastatynu i piohlitazonu na pokaznyky homeostazu u khvorykh na osteoartroz z metabolichnym syndromom i aterosklerozom. Visnyk problem biolohiyi ta medytsyny. 2010;3:133–136. [in Ukrainian]
    • Kuryata AV, Cherkasova AV. Insulinorezistentnost i sistemnoye vospaleniye u patsiyentov s osteoartrozom v sochetanii s ozhireniyem: effektivnost simptomaticheskikh preparatov zamedlennogo deystviya. Travma. 2016;17(1):47–54. [in Russian]
    • Babinets LS, Halabitska IM. Characteristics of joint pain in patients with primary osteoarthritis and comorbid conditions with exocrine pancreatic insufficiency. Lekarsky Obzor. 2021;70(2):62–64. 
    • Berenbaum F, Griffin TM, Liu-Bryan R. Metabolic Regulation of Inflammation in Osteoarthritis. Arthritis Rheumatol. 2017 Jan;69(1):9–21. doi: 10.1002/art.39842.
    • Calay ES, Hotamisligil GS. Turning off the inflammatory, but not the metabolic, flames. Nat Med. 2013 Mar;19(3):265–7. doi: 10.1038/nm.3114.
    • Courties A, Sellam J, Berenbaum F. Metabolic syndrome-associated osteoarthritis. Curr Opin Rheumatol. 2017 Mar;29(2):214–222. doi: 10.1097/BOR.0000000000000373.
    • Felson DT. Osteoarthritis as a disease of mechanics. Osteoarthritis Cartilage. 2013 Jan;21(1):10–5. doi: 10.1016/j.joca.2012.09.012.
    • Han CD, Yang IH, Lee WS, Park YJ, Park KK al. Correlation between metabolic syndrome and knee osteoarthritis: data from the Korean National Health and Nutrition Examination Survey (KNHANES). BMC Public Health. 2013;13:603.
    • Laiguillon MC, Courties A, Houard X, Auclair M, Sautet A, et al. Characterization of diabetic osteoarthritic cartilage and role of high glucose environment on chondrocyte activation: toward pathophysiological delineation of diabetes mellitus-related osteoarthritis. Osteoarthritis Cartilage. 2015 Sep;23(9):1513–22. doi: 10.1016/j.joca.2015.04.026. 
    • Yoshimura N, Muraki S, Oka H, Tanaka S, Kawaguchi H, Nakamura K, et al. Accumulation of metabolic risk factors such as overweight, hypertension, dyslipidaemia, and impaired glucose tolerance raises the risk of occurrence and progression of knee osteoarthritis: a 3-year follow-up of the ROAD study. Osteoarthritis Cartilage. 2012 Nov;20(11):1217–26. doi: 10.1016/j.joca.2012.06.006.
    Publication of the article «World of Medicine and Biology» №4(78), 2021 year, 056-060 pages, index UDK 616.72-002-085
    DOI 10.26724/2079-8334-2021-4-78-56-60